University Library
  • Login
A gateway to Melbourne's research publications
Minerva Access is the University's Institutional Repository. It aims to collect, preserve, and showcase the intellectual output of staff and students of the University of Melbourne for a global audience.
View Item 
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Melbourne Medical School
  • Surgery (RMH)
  • Surgery (RMH) - Research Publications
  • View Item
  • Minerva Access
  • Medicine, Dentistry & Health Sciences
  • Melbourne Medical School
  • Surgery (RMH)
  • Surgery (RMH) - Research Publications
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

    Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer.

    Thumbnail
    Download
    Published version (1.460Mb)

    Citations
    Scopus
    Web of Science
    Altmetric
    16
    14
    Author
    Morrow, RJ; Etemadi, N; Yeo, B; Ernst, M
    Date
    2017
    Source Title
    Mediators of Inflammation
    Publisher
    Hindawi Limited
    University of Melbourne Author/s
    Ernst, Matthias
    Affiliation
    Surgery (RMH)
    Metadata
    Show full item record
    Document Type
    Journal Article
    Citations
    Morrow, R. J., Etemadi, N., Yeo, B. & Ernst, M. (2017). Challenging a Misnomer? The Role of Inflammatory Pathways in Inflammatory Breast Cancer.. Mediators Inflamm, 2017, pp.4754827-. https://doi.org/10.1155/2017/4754827.
    Access Status
    Open Access
    URI
    http://hdl.handle.net/11343/256301
    DOI
    10.1155/2017/4754827
    Open Access at PMC
    http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5457777
    Abstract
    Inflammatory breast cancer is a rare, yet highly aggressive form of breast cancer, which accounts for less than 5% of all locally advanced presentations. The clinical presentation of inflammatory breast cancer often differs significantly from that of noninflammatory breast cancer; however, immunohistochemistry reveals few, if any, distinguishing features. The more aggressive triple-negative and HER2-positive breast cancer subtypes are overrepresented in inflammatory breast cancer compared with noninflammatory breast cancer, with a poorer prognosis in response to conventional therapies. Despite its name, there remains some controversy regarding the role of inflammation in inflammatory breast cancer. This review summarises the current molecular evidence suggesting that inflammatory signaling pathways are upregulated in this disease, including NF-κB activation and excessive IL-6 production among others, which may provide an avenue for novel therapeutics. The role of the tumor microenvironment, through tumor-associated macrophages, infiltrating lymphocytes, and cancer stem cells is also discussed, suggesting that these tumor extrinsic factors may help account for the differences in behavior between inflammatory breast cancer and noninflammatory breast cancer. While there are various novel treatment strategies already underway in clinical trials, the need for further development of preclinical models of this rare but aggressive disease is paramount.

    Export Reference in RIS Format     

    Endnote

    • Click on "Export Reference in RIS Format" and choose "open with... Endnote".

    Refworks

    • Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References


    Collections
    • Minerva Elements Records [45770]
    • Surgery (RMH) - Research Publications [264]
    Minerva AccessDepositing Your Work (for University of Melbourne Staff and Students)NewsFAQs

    BrowseCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects
    My AccountLoginRegister
    StatisticsMost Popular ItemsStatistics by CountryMost Popular Authors